Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: This case is based on the Doctrine of Equivalents, but the DoE is complicated

volume is 413,00 & 175,000 shares & .. far more than the average.... looks like we will see an up day today....

Share
New Message
Please login to post a reply